Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Stegall

Showing results (31-40 of 202) with videos related to

Pageof 21
Sort By:
Clinical Transplants|May 18, 2017
Should We Be Performing More Pancreas Transplants?Keisha P Bonner, Yogish C Kudva, Mark D Stegall, et al.
Transplantation|September 24, 2013
Down-regulating humoral immune responses: implications for organ transplantationMark D Stegall, Natalie Moore, Timucin Taner, et al.
Transplantation|October 10, 2012
Identification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal functionWalter D Park, Timothy S Larson, Matthew D Griffin, et al.
Transplantation|September 28, 2002
Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch eraMark D Stegall, Patrick G Dean, Maureen A McBride, et al.
Transplantation|June 15, 2007
Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplantWalter Park, Matthew Griffin, Joseph P Grande, et al.
Transplantation|October 20, 2015
Reassessing Preemptive Kidney Transplantation in the United States: Are We Making Progress?Colleen L Jay, Patrick G Dean, Ryan A Helmick, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2016
Predicting Individual Renal Allograft Outcomes Using Risk Models with 1-Year Surveillance Biopsy and Alloantibody DataManuel Moreno Gonzales, Andrew Bentall, Walter K Kremers, et al.
Transplant Immunology|July 21, 2012
The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allograftsBrian K Goh, Marcio F Chedid, James M Gloor, et al.
Human Immunology|August 25, 2016
Why do we have the kidney allocation system we have today? A history of the 2014 kidney allocation systemMark D Stegall, Peter G Stock, Kenneth Andreoni, et al.
Transplantation|August 20, 2014
Compensatory hypertrophy of the remaining kidney in medically complex living kidney donors over the long termTimucin Taner, Corey W Iqbal, Stephen C Textor, et al.
Pageof 21

Showing results (31-40 of 202) with videos related to

Sort By:
Pageof 21
Clinical Transplants|May 18, 2017
Should We Be Performing More Pancreas Transplants?Keisha P Bonner, Yogish C Kudva, Mark D Stegall, et al.
Transplantation|September 24, 2013
Down-regulating humoral immune responses: implications for organ transplantationMark D Stegall, Natalie Moore, Timucin Taner, et al.
Transplantation|October 10, 2012
Identification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal functionWalter D Park, Timothy S Larson, Matthew D Griffin, et al.
Transplantation|September 28, 2002
Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch eraMark D Stegall, Patrick G Dean, Maureen A McBride, et al.
Transplantation|June 15, 2007
Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplantWalter Park, Matthew Griffin, Joseph P Grande, et al.
Transplantation|October 20, 2015
Reassessing Preemptive Kidney Transplantation in the United States: Are We Making Progress?Colleen L Jay, Patrick G Dean, Ryan A Helmick, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2016
Predicting Individual Renal Allograft Outcomes Using Risk Models with 1-Year Surveillance Biopsy and Alloantibody DataManuel Moreno Gonzales, Andrew Bentall, Walter K Kremers, et al.
Transplant Immunology|July 21, 2012
The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allograftsBrian K Goh, Marcio F Chedid, James M Gloor, et al.
Human Immunology|August 25, 2016
Why do we have the kidney allocation system we have today? A history of the 2014 kidney allocation systemMark D Stegall, Peter G Stock, Kenneth Andreoni, et al.
Transplantation|August 20, 2014
Compensatory hypertrophy of the remaining kidney in medically complex living kidney donors over the long termTimucin Taner, Corey W Iqbal, Stephen C Textor, et al.
Pageof 21